Literature DB >> 9441707

Molecular evidence for the involvement of alpha crystallin in the colouration/crosslinking of crystallins in age-related nuclear cataract.

Y C Chen1, G E Reid, R J Simpson, R J Truscott.   

Abstract

The proteins of the lens which become insoluble, crosslinked and coloured as a result of the onset of human nuclear cataract have been studied using a combination of enzymatic digestion and HPLC/mass spectrometry (MS). The objective was to determine if such an approach could provide information on the identities of the polypeptide components involved in the colouration and crosslinking and to discover whether any crystallins predominate in this characteristic post-translational modification process. Initially, coloured high molecular weight peptides were isolated from a tryptic/chymotryptic digest of the 6 M guanidine hydrochloride-insoluble lens protein fraction. These tryptic/chymotryptic peptides were then incubated with pronase and the small peptides released, purified by gel filtration. All but one of the peptides analysed by HPLC/MS/MS were found to contain proline. Peptides derived from alpha-crystallin were found to comprise the great majority of the peptides characterised. No gamma-crystallin peptides were observed. Both alpha A-crystallin and alpha B-crystallin were represented. Further, all but one of these peptides were derived from the N-terminal region of the alpha-crystallin subunits: a region recently implicated in the chaperone activity of alpha-crystallin. This finding suggests that the putative N-terminal domain of alpha-crystallin may be involved at the molecular level in the process of crosslinking and colouration which is known to be characteristic of age-related nuclear cataract. It is, therefore, conceivable that an early stage of these cataractous modifications may involve alpha-crystallin acting as a molecular chaperone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441707     DOI: 10.1006/exer.1997.0393

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

1.  UVA light-excited kynurenines oxidize ascorbate and modify lens proteins through the formation of advanced glycation end products: implications for human lens aging and cataract formation.

Authors:  Mikhail Linetsky; Cibin T Raghavan; Kaid Johar; Xingjun Fan; Vincent M Monnier; Abhay R Vasavada; Ram H Nagaraj
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

2.  A comparative study of monoclonal antibodies. 1. Phase behavior and protein-protein interactions.

Authors:  Rachael A Lewus; Nicholas E Levy; Abraham M Lenhoff; Stanley I Sandler
Journal:  Biotechnol Prog       Date:  2014-11-19

3.  αB-crystallin/sHSP protects cytochrome c and mitochondrial function against oxidative stress in lens and retinal cells.

Authors:  Rebecca S McGreal; Wanda Lee Kantorow; Daniel C Chauss; Jianning Wei; Lisa A Brennan; Marc Kantorow
Journal:  Biochim Biophys Acta       Date:  2012-04-12

4.  Identification of Kynoxazine, a Novel Fluorescent Product of the Reaction between 3-Hydroxykynurenine and Erythrulose in the Human Lens, and Its Role in Protein Modification.

Authors:  Stefan Rakete; Ram H Nagaraj
Journal:  J Biol Chem       Date:  2016-03-03       Impact factor: 5.157

5.  Chaperone-independent mitochondrial translocation and protection by αB-crystallin in RPE cells.

Authors:  Rebecca S McGreal; Lisa A Brennan; Wanda Lee Kantorow; Jeffrey D Wilcox; Jianning Wei; Daniel Chauss; Marc Kantorow
Journal:  Exp Eye Res       Date:  2013-03-04       Impact factor: 3.467

6.  Effect of Mild Heating on Human Lens Epithelial Cells: A Possible Model of Lens Aging.

Authors:  Keke Zhang; Xiangjia Zhu; Yi Lu
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

Review 7.  Chemical Properties Determine Solubility and Stability in βγ-Crystallins of the Eye Lens.

Authors:  Megan A Rocha; Marc A Sprague-Piercy; Ashley O Kwok; Kyle W Roskamp; Rachel W Martin
Journal:  Chembiochem       Date:  2021-02-10       Impact factor: 3.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.